| 1 |
Reuben A, Koch DG, Lee WM, et al. Drug-induced acute liver failure: results of a U．S. multicenter, prospective study[J]. Hepatology, 2010, 52(6): 2065-2076.
|
| 2 |
Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver Injury in mainland China[J]. Gastroenterology, 2019, 156(8): 2230-2241. e11.
|
| 3 |
Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries[J]. J Clin Epidemiol, 1993, 46(11): 1323-1330.
|
| 4 |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 实用肝脏病杂志，2017, 20(2): 257-274.
|
| 5 |
Stravitz RT, Lee WM. Acute liver failure[J]. Lancet, 2019, 394(10201): 869-881.
|
| 6 |
中华人民共和国卫生部. 中国人体器官分配与共享基本原则和肝脏与肾脏移植核心政策[J/CD]. 实用器官移植电子杂志，2013, 1(2): 67-71.
|
| 7 |
Lee WM, Squires Jr RH, Nyberg SL, et al. Acute liver failure: Summary of a workshop[J]. Hepatology, 2008, 47(4): 1401-1415.
|
| 8 |
Mindikoglu AL, Magder LS, Regev A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database[J]. Liver Transpl, 2009, 15(7): 719-729.
|
| 9 |
Germani G, Theocharidou E, Adam R, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database[J]. J Hepatol, 2012, 57(2): 288-296.
|
| 10 |
Yamashiki N, Sugawara Y, Tamura S, et al. Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey[J]. Liver Transpl, 2012, 18(9): 1069-1077.
|
| 11 |
Choudhary NS, Saigal S, Saraf N, et al. Good outcome of living donor liver transplantation in drug-induced acute liver failure: A single-center experience[J]. Clin Transplant, 2017, 31(3)．
|
| 12 |
Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B[J]. Hepatology, 1986, 6(4): 648-651.
|
| 13 |
Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators[J]. Hepatology, 1993, 18(6): 1370-1376.
|
| 14 |
Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity[J]. Hepatology, 2002, 36(3): 659-665.
|
| 15 |
Bernal W, Donaldson N, Wyncoll D, et al. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study[J]. Lancet, 2002, 359(9306): 558-563.
|
| 16 |
Mitchell I, Bihari D, Chang R, et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure[J]. Crit Care Med, 1998, 26(2): 279-284.
|
| 17 |
Hadem J, Stiefel P, Bahr MJ, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure[J]. Clin Gastroenterol Hepatol, 2008, 6(3): 339-345.
|
| 18 |
Zabron A, Quaglia A, Fatourou E, et al. Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure[J]. Liver Int, 2018, 38(9): 1592-1601.
|
| 19 |
O′Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure[J]. Gastroenterology, 1989, 97(2): 439-445.
|
| 20 |
McPhail MJ, Farne H, Senvar N, et al. Ability of King′s College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: A meta-analysis[J]. Clin Gastroenterol Hepatol, 2016, 14(4): 516-525. e5; quiz e43-e45.
|
| 21 |
Cholongitas E, Theocharidou E, Vasianopoulou P, et al. Comparison of the sequential organ failure assessment score with the King′s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure[J]. Liver Transpl, 2012, 18(4): 405-412.
|
| 22 |
Koch DG, Tillman H, Durkalski V, et al. Development of a model to predict transplant-free survival of patients with cute liver failure[J]. Clin Gastroenterol Hepatol, 2016, 14(8): 1199-1206. e2.
|
| 23 |
Chayanupatkul M, Schiano TD. Acute liver failure secondary to drug-induced liver injury[J]. Clin Liver Dis, 2020, 24(1): 75-87.
|
| 24 |
Au KP, Chan SC, Chok KS, et al. Clinical factors affecting rejection rates in liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2015, 14(4): 367-373.
|
| 25 |
Barshes NR, Lee TC, Balkrishnan R, et al. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure[J]. Transplantation, 2006, 81(2): 195-201.
|